This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager.
Dismiss

China warns against duplication as provinces race into future industries

By MLex Staff ( August 5, 2026, 07:36 GMT | Insight) -- China is warning that an accelerating nationwide race into future industries could undermine innovation and distort competition, as nearly every province pursues many of the same strategic sectors despite significant differences in industrial foundations and resource endowments. A survey published Monday by the Chinese Communist Party-backed Economic Daily found that almost every province has prioritized hydrogen, 29 included biomanufacturing, more than 20 targeted embodied intelligence, while around half also identified quantum technology, brain-computer interfaces and 6G.China is warning that an accelerating nationwide race into future industries could undermine innovation and distort competition, as nearly every province pursues many of the same strategic sectors despite significant differences in industrial foundations and resource endowments....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login